Search Results - "Neuro-oncology" :: UTM Library Massive Scholar Tracking

1

Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin by Corinna Seliger, Anne-Louise Meyer, Verena Leidgens, Lisa Rauer, Sylvia Moeckel, Birgit Jachnik, Judith Proske, Katja Dettmer, Tanja Rothhammer-Hampl, Leon D. Kaulen, Markus J. Riemenschneider, Peter J. Oefner, Marina Kreutz, Nils-Ole Schmidt, Marsha Merrill, Martin Uhl, Kathrin Renner, Arabel Vollmann-Zwerenz, Martin Proescholdt, Peter Hau

Published 2022-10-01

Get full text

Article

2

Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells by Corinna Seliger, Lisa Rauer, Anne-Louise Wüster, Sylvia Moeckel, Verena Leidgens, Birgit Jachnik, Laura-Marie Ammer, Simon Heckscher, Katja Dettmer, Markus J. Riemenschneider, Peter J. Oefner, Martin Proescholdt, Arabel Vollmann-Zwerenz, Peter Hau

Published 2023-02-01

Get full text

Article

3

TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma by Ayse N. Menevse, Laura-Marie Ammer, Arabel Vollmann-Zwerenz, Marcell Kupczyk, Julia Lorenz, Lorraine Weidner, Abir Hussein, Julian Sax, Jasmin Mühlbauer, Nicole Heuschneider, Celine Rohrmus, Laura S. Mai, Birgit Jachnik, Slava Stamova, Valentina Volpin, Franziska C. Durst, Antonio Sorrentino, Maria Xydia, Vladimir M. Milenkovic, Stefanie Bader, Frank K. Braun, Christian Wetzel, Nathalie L. Albert, Joerg-Christian Tonn, Peter Bartenstein, Martin Proescholdt, Nils O. Schmidt, Ralf A. Linker, Markus J. Riemenschneider, Philipp Beckhove, Peter Hau

Published 2023-05-01

Get full text

Article

4

Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma by Tareq M. Haedenkamp, Michael F. Leitzmann, Ralf A. Linker, Christoph Meier, Claudia Becker, Susan Jick, Katharina Sahm, Michael Platten, Peter Hau, Corinna Seliger

Published 2020-02-01

Get full text

Article

5

The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma by Laura-Marie Ammer, Arabel Vollmann-Zwerenz, Viktoria Ruf, Christian H. Wetzel, Markus J. Riemenschneider, Nathalie L. Albert, Philipp Beckhove, Peter Hau

Published 2020-10-01

Get full text

Article

6

Antimicrobial drug use and the risk of glioma: A case–control study by Tareq M. Haedenkamp, Michael F. Leitzmann, Ralf A. Linker, Christoph Meier, Claudia Becker, Susan Jick, Peter Hau, Corinna Seliger

Published 2023-02-01

Get full text

Article

7

Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning by Elisabeth Bumes, Claudia Fellner, Franz A. Fellner, Karin Fleischanderl, Martina Häckl, Stefan Lenz, Ralf Linker, Tim Mirus, Peter J. Oefner, Christian Paar, Martin Andreas Proescholdt, Markus J. Riemenschneider, Katharina Rosengarth, Serge Weis, Christina Wendl, Sibylle Wimmer, Peter Hau, Wolfram Gronwald, Markus Hutterer

Published 2022-06-01

“…In clinical routine, however, non-invasive determination of IDH mutation status is desirable in cases where tumor biopsy is not possible and for monitoring neuro-oncological therapies. In a previous publication, we presented reliable prediction of IDH mutation status employing proton magnetic resonance spectroscopy (1H-MRS) on a 3.0 Tesla (T) scanner and machine learning in a prospective cohort of 34 glioma patients. …”

Get full text

Article

8